Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters

Language
Document Type
Year range
1.
Rev. Méd. Clín. Condes ; 32(1): 20-29, ene.-feb. 2021. ilus
Article in Spanish | WHO COVID, LILACS (Americas) | ID: covidwho-1244814

ABSTRACT

El Coronavirus SARS-CoV-2 produce la enfermedad COVID-19, cuya manifestación más grave y potencialmente letal es la neumonía. En este artículo revisaremos las manifestaciones clínicas del COVID-19, la fisiopatología de la neumonía, el manejo intrahospitalario previo al ingreso a Unidades de Cuidados Intensivos, la embolia pulmonar que es una complicación muy frecuente de esta enfermedad y el seguimiento de los pacientes posterior al alta. Para esta publicación nos hemos basado en publicaciones médicas y en estudios que hemos hecho durante esta pandemia en nuestro Centro de Enfermedades Respiratorias. i:es


The SARS-CoV-2 Coronavirus causes the COVID-19 disease, the most severe and potentially fatal manifestation of which is pneumonia. In this article, we will review the clinical manifestations of COVID-19, the pathophysiology of pneumonia, in-hospital management prior to admission to Intensive Care Units, pulmonary embolism, which is a very frequent complication of this disease, and the follow-up of patients after hospitalization. For this publication we have relied on medical publications and studies that we have done during this pandemic at our Center for Respiratory Diseases. i:en


Subject(s)
Humans , Pneumonia/physiopathology , Pneumonia/therapy , COVID-19/physiopathology , COVID-19/therapy , Oxygen Inhalation Therapy , Pneumonia/etiology , Pulmonary Embolism , Risk Factors , Adrenal Cortex Hormones/therapeutic use , Noninvasive Ventilation , SARS-CoV-2/pathogenicity , COVID-19/complications , COVID-19/diagnosis
SELECTION OF CITATIONS
SEARCH DETAIL